70
Participants
Start Date
December 9, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Tasimelteon
oral capsule
Placebo
oral capsule
RECRUITING
Vanda Investigational Site, Vienna
RECRUITING
Vanda Investigational Site, Linz
ACTIVE_NOT_RECRUITING
Vanda Investigational Site, Innsbruck
RECRUITING
Vanda Investigational Site, Berlin
RECRUITING
Vanda Investigational Site, New Hyde Park
RECRUITING
Vanda Investigational Site, Schwerin
RECRUITING
Vanda Investigational Site, Hamburg
RECRUITING
Vanda Investigational Site, Columbia
RECRUITING
Vanda Investigational Site, Miami
RECRUITING
Vanda Investigational Site, Marburg
RECRUITING
Vanda Investigational Site, Cleveland
RECRUITING
Vanda Investigational Site, Cincinnati
RECRUITING
Vanda Investigational Site, Rochester
RECRUITING
Vanda Investigational Site, St Louis
RECRUITING
Vanda Investigational Site, McKinney
RECRUITING
Vanda Investigational Site, San Antonio
RECRUITING
Vanda Investigational Site, Aurora
RECRUITING
Vanda Investigational Site, Munich
RECRUITING
Vanda Investigational Site, Los Angeles
RECRUITING
Vanda Investigational Site, Redwood City
RECRUITING
Vanda Investigational Site, Boston
Lead Sponsor
Vanda Pharmaceuticals
INDUSTRY